Stefan Glück, MD, PhD, is Vice President, Global Medical Affairs at Celgene Corporation since October 2014; prior to that he was until September 2014 a Sylvester Professor in the Department of Medicine, Miller School of Medicine at the University of Miami in Miami, Florida. He is a medical oncologist with a focus on breast cancer. From 2003–2008, he was the Clinical Director of the Braman Family Breast Cancer Institute, from January 2009 to December 2010 assistant Director of the Sylvester Comprehensive Cancer Center and Associate Chief, Division Hematology and Medical Oncology. Dr. Glück was presented the America’s Top Oncologists 2008 award from Consumers’ Research Council of America; he also received the Best Doctors in America honor in since 2006, and has annually earned that prestige every year, including in 2014; this award was warranted after less than 3 years of working in the United States.
Title : Vaccine for AML: 2023 and beyond